Related Experiment Videos
[Bronchoplastic operations for lung cancer]
Saulius Cicenas1, Pranciskus Naujokaitis, Algirdas Jackevicius
1Department of Thoracic Surgery, Institute of Oncology, Vilnius University, Santariskiu 1, 2600 Vilnius, Lithuania.
Medicina (Kaunas, Lithuania)
|February 1, 2003
Summary
Bronchoplastic operations are effective for early-stage lung cancer, with a three-year survival rate of 82.4%. Combined treatment shows promising results, though some patients experience disease progression.
Area of Science:
- Thoracic Surgery
- Oncology
- Pulmonary Medicine
Background:
- Lung cancer treatment requires effective surgical interventions.
- Bronchoplastic operations offer lung-sparing alternatives.
- Evaluating outcomes of these procedures is crucial.
Purpose of the Study:
- To assess the efficacy of bronchoplastic operations in early-stage lung cancer.
- To determine the time to progression in patients receiving combined treatment.
Main Methods:
- A cohort of 57 patients with early-stage lung cancer (I-IIB) underwent various bronchoplastic procedures.
- Surgical techniques included tracheal resections, pneumonectomies, and sleeve resections.
- Postoperative treatments involved radiation and/or chemotherapy.
Main Results:
- Three-year survival rate was 82.4% (47 patients).
- Disease progression occurred in 17.4% (10 patients) within three years.
- Complications included suture failure (12.2%) and obstructive pneumonia (45.6%).
Conclusions:
- Bronchoplastic operations are a sufficient treatment modality for early-stage lung cancer.
- Combined treatment approaches yield a high three-year survival rate.
- Further research into minimizing complications is warranted.